Skip to content

Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk

Proteomics of Cerebrospinal Fluid of Preterm Infants With Posthemorrhagic Hydrocephalus With Focus on Intranasal Breast Milk.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04229693
Acronym
NAMU
Enrollment
20
Registered
2020-01-18
Start date
2020-02-07
Completion date
2021-08-31
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus in Infants

Brief summary

Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence of breastmilk feeding and way of application such as via gavage tube, oral or nasal application.

Detailed description

Since the nasal route might be highly effective for neurotrophins and other growth factors the cerebrospinal fluid will be investigated using mass spectrometry to identify modulating effects of intranasal breast milk application on the cerebrospinal fluid proteom.

Interventions

OTHERno intervention

no intervention, only observational.

Sponsors

University Hospital of Cologne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Days to 12 Months
Healthy volunteers
No

Inclusion criteria

* preterm infant with hydrocephalus and regular drainage

Exclusion criteria

* Inborn error of metabolism

Design outcomes

Primary

MeasureTime frameDescription
Cerebrospinal fluid proteomweeksCerebrospinal fluid analysis using mass spectrometry including proteomic analysis for differences in dependence of intranasal breast milk application

Countries

Germany

Contacts

Primary ContactTitus Keller, MD
titus.keller@uk-koeln.de0049 221 4449
Backup ContactAngela Kribs, MD
angela.kribs@uk-koeln.de0049 221 5998

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026